CAS: 614751-80-3

Gatifloxacin hydrate is a fluoroquinolone antibiotic, which is synthesized chemically. It exerts its bactericidal effects primarily by inhibiting bacterial DNA gyrase and topoisomerase IV. These enzymes are crucial for bacterial DNA replication, transcription, and repair. By preventing these processes, gatifloxacin effectively halts bacterial cell division, ultimately leading to cell death. Gatifloxacin hydrate is utilized extensively in the treatment of various bacterial infections, particularly those affecting the respiratory tract, skin, and urinary tract. Its broad-spectrum activity ensures it is effective against both Gram-positive and Gram-negative bacteria. Given its potent antibacterial properties, gatifloxacin is a valuable tool in managing infections that are resistant to other antibiotics, particularly in clinical settings. Proper utilization and adherence to prescribed regimens are essential to maintaining its efficacy and mitigating resistance development.